ACACIA-HCM is the First Phase 3 Clinical Trial to Successfully Demonstrate Statistically Significant Improvements Across Both Patient-Reported and Physician-Assessed Endpoints in Non-Obstructive HCM ...
Aficamten treatment was associated with significant improvements in symptom burden and exercise capacity in patients with ...
Cytokinetics (NASDAQ:CYTK) presented primary results from its Phase III ACACIA-HCM trial evaluating aficamten in patients ...
Learn how to create interactive websites without relying on JavaScript.
Researchers show how invisible HTML can inject hidden instructions into an AI email summarizer and silently manipulate the ...
As Ireland steps up its wind energy capacity, Neil Michael learns that our flawed model for ensuring communities benefit from ...
When I’m in the thick of the action and see an agent miss finding a document that should exist, I can respond with focused ...
AI is advancing at a rapid rate, and Ollama claims its Qwen3-VL is the most powerful vision language model yet. Here's what ...
Learn the benefits and challenges of an in-house design system and how a dedicated team can improve development, branding and accessibility.
A bookstore's AI-altered ad exposed a gap most marketing teams haven't fixed – nobody owns what AI changes after approval.
At this self-managed facility, reintegration is the priority. The recidivism rate is far lower than that of the traditional ...
The builder ships alongside AWeber's AI Signup Form Builder, with an AI email builder arriving this fall. Every page connects ...